Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

Novartis India Debt & Borrowing

Novartis India Limited confirmed it does not qualify as a 'Large Corporate' for FY 2025-26 per SEBI debt-raising norms. The company reported zero outstanding long-term borrowings as of March 31, 2025. This routine regulatory disclosure indicates the company is not currently subject to mandatory incremental borrowing through debt securities.

Source

BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Novartis India Ltd: key numbers

Share price
₹1,728.35
Market cap
₹4,267 Cr
Revenue (annual)
₹354.3 Cr
Net profit (annual)
₹93.18 Cr
P/E (TTM)
43.6×Sector 47.2×
Promoter holding
70.68%+0.00% QoQ
FII holding
1.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Novartis India Ltd

All →
19:01 IST BSE
Fund Raise

Novartis India Fund Raise of ₹900 Cr

Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.

Value
₹900.0 Cr

Other debt & borrowing announcements

All →